EMEA-002303-PIP01-17-M02

Table of contents

Key facts

Active substance
Etripamil
Therapeutic area
Cardiovascular diseases
Decision number
P/0406/2020
PIP number
EMEA-002303-PIP01-17-M02
Pharmaceutical form(s)
Nasal spray, solution
Condition(s) / indication(s)
Treatment of supraventricular arrhythmias
Route(s) of administration
Intranasal use
Contact for public enquiries
Milestone Pharmaceuticals Inc.

Tel. +1 514330444
E-mail: info@milestonepharma.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating